Drugs / FOLF+B
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05329103 Background | Jul 2022 → Oct 2026 expected | neoplasm | Peel Therapeutics Inc | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FOLF+B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05329103 ↗ |